ended7월 28일· 1 sources
As US measles cases rise, biotech firms start developing new treatments
Why it matters
Up until recently, measles vaccination has been so effective that there’s been little medical or financial incentive to develop treatments for the disease. But as measles cases hit a 35-year high and ...
1
Sources
+0
24h
—
Growth
5d
Active